Live News Categoriesmarket

RKV.V (RKV.V) News

Follow RKV.V (RKV.V) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol RKV.V Asset market Sector Markets 90 days 1 Updated Oct 14, 2026, 09:31 AM UTC Open live news feed

L Rakovina Therapeutics expands Variational AI pact, gains exclusivity on kt — 5000 ATR inhibitor target profile Rakovina Therapeutics amended, extended its research services deal with Variational AI for the kt-5000 ATR inhibitor program. Amendment grants exclusivity on a defined target product profile covering potency, selectivity NEWS | Oct 14, 2026, 09:31 AM UTC